Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06286566Not ApplicableNot Yet Recruiting

Soi TS3 Surface in Patients With and Without Type 2 Diabetes

Role: collaborator

NCT06286605Not ApplicableNot Yet Recruiting

RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A

Role: collaborator

NCT06286579Not ApplicableNot Yet Recruiting

SOI Immediately vs Delayed

Role: collaborator

NCT06276712Not ApplicableNot Yet Recruiting

RCT Comparing KS Versus TS for Ovedenture

Role: collaborator

NCT05843981Not ApplicableNot Yet Recruiting

Comparison KS Versus TS

Role: collaborator

NCT05847907Not ApplicableNot Yet Recruiting

RCT KS-SA Versur KS-BA in Diabetic Patients

Role: collaborator

All 6 trials loaded